XL765
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for XL765, covering 2012-02-03 to 2016-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer [Phase 1, Phase 2]